Intestinal Barrier Dysfunction and Microbial Translocation in Human Immunodeficiency Virus-Infected Pregnant Women Are Associated With Preterm Birth

In our study of HIV-1-infected pregnant women, those with higher levels of markers for monocyte activation and intestinal integrity dysfunction during pregnancy had an increased odds of preterm delivery. Interventions targeting gut integrity and microbial translocation may help reduce preterm birth....

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2018-09, Vol.67 (7), p.1103-1109
Main Authors: Shivakoti, Rupak, Gupte, Nikhil, Kumar, Nathella Pavan, Kulkarni, Vandana, Balasubramanian, Usha, Bhosale, Ramesh, Sambrey, Pradeep, Kinikar, Aarti, Bharadwaj, Renu, Patil, Sandesh, Inamdar, Sadaf, Suryavanshi, Nishi, Babu, Subash, Bollinger, Robert C, Gupta, Amita
Format: Article
Language:English
Subjects:
Adult
and Commentaries
Anti-HIV Agents - therapeutic use
Bacterial Translocation
Case-Control Studies
Editor's Choice
Female
HIV Infections - complications
HIV Infections - drug therapy
Humans
Infant, Newborn
Intestinal Mucosa - pathology
Pregnancy
Pregnancy Complications, Infectious
Premature Birth - etiology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In our study of HIV-1-infected pregnant women, those with higher levels of markers for monocyte activation and intestinal integrity dysfunction during pregnancy had an increased odds of preterm delivery. Interventions targeting gut integrity and microbial translocation may help reduce preterm birth. Abstract Background Preterm birth (PTB) rates are high in human immunodeficiency virus (HIV)-infected populations, even when on treatment. Still, only a subset of all births in HIV-infected pregnant women result in PTB, suggesting that risk factors other than HIV infection itself are also important. Inflammation is a known risk factor in uninfected populations, but its role in HIV-infected population have not been studied; in addition, the immune pathways involved are not clear and noninvasive immune markers with predictive value are lacking. Our objective was to determine the association of select markers of inflammation with PTB in HIV-1-infected pregnant women. Methods Within a randomized trial of pregnant women receiving nevirapine (Six-Week Extended-Dose Nevirapine [SWEN] trial), we nested a case-control study (n = 107; 26 cases, 81 controls) to determine the association of maternal inflammation with PTB. Cases were defined as PTB (
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciy253